Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Clinical trial NCT07270263 · RECRUITING

Trial details

NCT number: NCT07270263
Sponsor: Medical University of Gdansk
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoma Leukemia Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Venous Thromboembolic Disease VTE (Venous Thromboembolism)PE - Pulmonary Embolism Hematologic Malignacies

Start date: 2024-11-22
Primary completion: 2026-04-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.